Cargando…

EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis

EZH2 inhibition and reactivation of tumor suppressor microRNAs (miRNAs) represent attractive anti-cancer therapeutic strategies. We found that EZH2-suppressed let 7b and miR-361, two likely tumor suppressors, inhibited endometrial cancer (EC) cell proliferation and invasion, and abrogated cancer ste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ihira, Kei, Dong, Peixin, Xiong, Ying, Watari, Hidemichi, Konno, Yosuke, Hanley, Sharon JB, Noguchi, Masayuki, Hirata, Noriyuki, Suizu, Futoshi, Yamada, Takahiro, Kudo, Masataka, Sakuragi, Noriaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355116/ https://www.ncbi.nlm.nih.gov/pubmed/28088786 http://dx.doi.org/10.18632/oncotarget.14586

Ejemplares similares

Suppression of iASPP-dependent aggressiveness in cervical cancer through reversal of methylation silencing of microRNA-124
por: Dong, Peixin, et al.
Publicado: (2016)

MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells
por: Konno, Yosuke, et al.
Publicado: (2014)

MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells
por: Dong, Peixin, et al.
Publicado: (2016)

Reactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wild-type tumors
por: Dong, Peixin, et al.
Publicado: (2015)

Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression
por: Dong, Peixin, et al.
Publicado: (2016)

MicroRNA-361: A Multifaceted Player Regulating Tumor Aggressiveness and Tumor Microenvironment Formation
por: Xu, Daozhi, et al.
Publicado: (2019)

Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving STAT3 and tumor microenvironment-related genes
por: Dong, Peixin, et al.
Publicado: (2019)

MicroRNA-361-Mediated Inhibition of HSP90 Expression and EMT in Cervical Cancer Is Counteracted by Oncogenic lncRNA NEAT1
por: Xu, Daozhi, et al.
Publicado: (2020)

Long non-coding RNA DLEU2 drives EMT and glycolysis in endometrial cancer through HK2 by competitively binding with miR-455 and by modulating the EZH2/miR-181a pathway
por: Dong, Peixin, et al.
Publicado: (2021)

The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer
por: Dong, Peixin, et al.
Publicado: (2014)

Emerging Therapeutic Biomarkers in Endometrial Cancer
por: Dong, Peixin, et al.
Publicado: (2013)

PD-L1 Is a Tumor Suppressor in Aggressive Endometrial Cancer Cells and Its Expression Is Regulated by miR-216a and lncRNA MEG3
por: Xu, Daozhi, et al.
Publicado: (2020)

The Expression, Functions and Mechanisms of Circular RNAs in Gynecological Cancers
por: Dong, Peixin, et al.
Publicado: (2020)

Long Non-Coding RNA TMPO-AS1 Promotes GLUT1-Mediated Glycolysis and Paclitaxel Resistance in Endometrial Cancer Cells by Interacting With miR-140 and miR-143
por: Dong, Peixin, et al.
Publicado: (2022)

Critical Roles of PIWIL1 in Human Tumors: Expression, Functions, Mechanisms, and Potential Clinical Implications
por: Dong, Peixin, et al.
Publicado: (2021)

Nerve-sparing radical hysterectomy in the precision surgery for cervical cancer
por: Sakuragi, Noriaki, et al.
Publicado: (2020)

Lymphadenectomy can be omitted for low-risk endometrial cancer based on preoperative assessments
por: Mitamura, Takashi, et al.
Publicado: (2014)

Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer
por: Miao, Yu, et al.
Publicado: (2023)

MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1
por: Dong, Peixin, et al.
Publicado: (2011)

miR-34a, miR-424 and miR-513 inhibit MMSET expression to repress endometrial cancer cell invasion and sphere formation
por: Dong, Peixin, et al.
Publicado: (2018)

Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4–miR-18a pathway in cervical cancer
por: Dong, Peixin, et al.
Publicado: (2018)

Correction: Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4–miR-18a pathway in cervical cancer
por: Dong, Peixin, et al.
Publicado: (2019)

Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis
por: Zhang, Qi, et al.
Publicado: (2017)

Multivariate prognostic analysis of adenocarcinoma of the uterine cervix treated with radical hysterectomy and systematic lymphadenectomy
por: Kato, Tatsuya, et al.
Publicado: (2013)

Oncological Outcomes After Okabayashi-Kobayashi Radical Hysterectomy for Early and Locally Advanced Cervical Cancer
por: Sakuragi, Noriaki, et al.
Publicado: (2020)

Multivariate survival analysis of the patients with recurrent endometrial cancer
por: Odagiri, Tetsuji, et al.
Publicado: (2011)

Autophagy as a modulator of cell death machinery
por: Noguchi, Masayuki, et al.
Publicado: (2020)

Apoptosis and Molecular Targeting Therapy in Cancer
por: Hassan, Mohamed, et al.
Publicado: (2014)

Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women
por: Aoyama‐Kikawa, Satomi, et al.
Publicado: (2018)

Correction: microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway
por: Mitamura, Takashi, et al.
Publicado: (2014)

Exploring lncRNA-Mediated Regulatory Networks in Endometrial Cancer Cells and the Tumor Microenvironment: Advances and Challenges
por: Dong, Peixin, et al.
Publicado: (2019)

Musashi-2, a novel oncoprotein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activation
por: Dong, Peixin, et al.
Publicado: (2017)

B7H3 As a Promoter of Metastasis and Promising Therapeutic Target
por: Dong, Peixin, et al.
Publicado: (2018)

Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion
por: Dong, Peixin, et al.
Publicado: (2018)

Phosphorylation‐dependent Akt–Inversin interaction at the basal body of primary cilia
por: Suizu, Futoshi, et al.
Publicado: (2016)

MicroRNA-361-5p Inhibits Tumorigenesis and the EMT of HCC by Targeting Twist1
por: Yin, Liang-Chun, et al.
Publicado: (2020)

Prognostic significance of miR-194 in endometrial cancer
por: Zhai, Haiyan, et al.
Publicado: (2013)

Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting Clusterin improves response to paclitaxel
por: Hassan, Mohamed K, et al.
Publicado: (2011)

P18/Stathmin1 is regulated by miR-31 in ovarian cancer in response to taxane
por: Hassan, Mohamed Kamel, et al.
Publicado: (2015)

microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway
por: Mitamura, Takashi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_323nerhdvnq5pt253ri1ol5jtt